Data from Pooled Analyses Demonstrates Welchol, Combined with Metformin- or Sulfonylurea-Based Therapy, Significantly Lowers Blood Glucose in Adults with Type ... (istics. (2) 2004 National Healthc...)

(Date:7/24/2008)...July 24 /PRNewswire-USNewswire/ -- Steven Mosher,...I), says that America has,a hidden problem of sex ...feminists refuse to address., In PRI,s latest You...,East and South Asian countries, of sex-selective ...actice has already claimed the lives of over 100,m...

(Date:7/24/2008)...July 24 /PRNewswire/ -- A new alliance of animal,l...roblems -- obesity -- in,pets and pet owners., Am...ne third of us are,obese, including 9 million chil...ok like us -- mirror us with similar health issues...partnership that includes,Harvard Medical Center, ...

(Date:7/24/2008)... CosmetaLife clinical trial results could lead ...cost-effective treatment for deep lines and wrinkl...inn. (PRWEB) July 24, 2008 -- Gel-Del Technologie...company announced that it has concluded clinical t...at company officials say holds potential to be a m...

(Date:7/24/2008)...RNewswire-FirstCall/ --, Key Highlights, Misys p...ns and is now,raising targets for the next phase o...) of GBP492m up 6%, bringing Group operating profi...xecuting on its strategy and entering,into the nex...m for growth., To view the Multimedia News Releas...

Breaking Medicine News(10 mins):Health News:PRI: Pro-Life Leader Blames Feminist Groups for Slaughter of Girls 2 Health News:PetFit Challenge Helps Keep Pets - and Pet Owners - Healthy 2 Health News:Clinical Trial Concluded For New Wrinkle Treatment 2 Health News:Clinical Trial Concluded For New Wrinkle Treatment 3 Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 2 Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 3 Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 4

[0] PRI: Pro-Life Leader Blames Feminist Groups for Slaughter of Girls [0] PetFit Challenge Helps Keep Pets - and Pet Owners - Healthy [0] Clinical Trial Concluded For New Wrinkle Treatment [0] Misys Announces Preliminary Results for the Year Ended 31 May 2008

...use it or lose it' advice when it comes keeping th...al stimulation can protect the brain from Alzheime... Disease Centre in the US now reveal new evidence ...ious Orders Study, involving the cognitive health ...

...with delirium run a much higher risk of death than...d there's a need for research to identify what cha... interventions that can be made after discharge to...covered 361 patients aged 65 or older, of whom 243...

... using new technology which helps prevent stroke. ...l stroke involves looking, by ultrasound, at any b...ain.// Researchers at Texas University in the US ...ice, based upon a technique called Power Doppler I...

...udies that one of the substance-propolis, a resino...e development of tooth decay. Researchers at the U...// considerably reduces dental plaque formation. P...ase (Gtf) enzymes, enzymes that synthesize glucans...

Other Medicine News:

Staying mentally energitic prevents Alzheimer's Delirium linked to death New device for detecting artery blockages Beehives to curb caries

(Date:7/23/2008)...Dendreon Corporation,(Nasdaq: DNDN ) today announ...g Committee (IDMC) to review in October 2008 the i...e Company,s Phase 3 IMPACT (IMmunotherapy,for Pros...B) clinical trial,of PROVENGE(R) (sipuleucel-T). P...llular immunotherapy for the treatment of advanced...

(Date:7/22/2008)...t Initiative bring MJFF,s,current active industry ...09, NEW YORK, July 22 /PRNewswire-USNewswire/ -- ...ormative treatments and a cure for Parkinson,s,dis...s Research has awarded,$2.7 million in total fundi... granted under MJFF,s Therapeutics Development Ini...

(Date:7/22/2008)...e to Patients of Passing a Follow-...ly 22 /- Insmed Inc. (Nasda... biopharmaceuticals, today,announced that Geoffrey...ngressional briefing on Friday, July 25th, 2008 to...approval pathway for follow-on,biologics (FOB) and...

(Date:7/22/2008)...re-FirstCall/ -- NicOx S.A.,(Euronext Paris: COX) ...enrollment of 417 osteoarthritis (OA) patients wit...logy studies in the United States, in line with,pr...igned to assess the,blood pressure profile of napr...using the Ambulatory Blood Pressure Monitoring (AB...

[0] Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October [0] Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics [0] Insmed CEO to Present at Congressional Briefing on Follow-On Biologics [0] NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients

... for New Aggrastat Study in American Heart Journal... Inc. (TSX:MPH;,Amex:MCU), a cardiovascular focuse... the two-year, follow-up results from the,STRATEGY...luting,Stent Versus Abciximab and Bare Metal Stent...hed in the July edition of the Journal,of the Amer...

...LD, Conn., July 11, 2007 /PRNewswire/ -- Phase 3 r...hat oral dabigatran,etexilate once daily, administ...o enoxaparin, also administered for an average of ...) and all-cause,mortality after total hip replacem...ding associated with dabigatran etexilate was,simi...

Other Medicine Technology:Positive Aggrastat Results Featured in the Journal of the American,College of Cardiology 2 Positive Aggrastat Results Featured in the Journal of the American,College of Cardiology 3 Positive Aggrastat Results Featured in the Journal of the American,College of Cardiology 4 Positive Aggrastat Results Featured in the Journal of the American,College of Cardiology 5 Phase 3 Results for Dabigatran Etexilate, an Investigational Oral,Anticoagulant, Presented Today at the XXIst Congress of the,International Society on Thrombosis and Haemostasis 2 Phase 3 Results for Dabigatran Etexilate, an Investigational Oral,Anticoagulant, Presented Today at the XXIst Congress of the,International Society on Thrombosis and Haemostasis 3 Phase 3 Results for Dabigatran Etexilate, an Investigational Oral,Anticoagulant, Presented Today at the XXIst Congress of the,International Society on Thrombosis and Haemostasis 4 Phase 3 Results for Dabigatran Etexilate, an Investigational Oral,Anticoagulant, Presented Today at the XXIst Congress of the,International Society on Thrombosis and Haemostasis 5

Positive Aggrastat Results Featured in the Journal of the American,College of Cardiology Phase 3 Results for Dabigatran Etexilate, an Investigational Oral,Anticoagulant, Presented Today at the XXIst Congress of the,International Society on Thrombosis and Haemostasis

The GENESIS II* Total Knee System will define the state of knee implants.

Cruciate Retaining, Posterior Stabilized and Constrained Components.

StelKast's Proven knee system is a long term, quality solution based on a clinically proven design. Available in both posterior stabilized and anatomically correct cruciate retaining configurations.

The Balanced Knee System provides instrumentation designed to achieve proper tissue balancing and alignment with user-friendly instrumentation that provides reproducible results.

Medicine Products:

GENESIS II* Total Knee System Ascent Primary Knee System Proven Cruciate Retaining Knee System Balanced Knee System

Data from Pooled Analyses Demonstrates Welchol, Combined with Metformin- or Sulfonylurea-Based Therapy, Significantly Lowers Blood Glucose in Adults with Type ...(istics. (2) 2004 National Healthc...),Health